Barrett's esophagus and Barrett's-related dysplasia

Modern Pathology

Volumn 16, Issue 4, 2003, Pages 316-324

  Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Barrett's esophagus; Dysplasia; Esophagus; Interobserver variation; Intestinal metaplasia

Indexed keywords

BIOLOGICAL MARKER;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER RISK; COLUMNAR EPITHELIUM; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DISEASE COURSE; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; GASTROESOPHAGEAL REFLUX; GOBLET CELL; HIGH RISK PATIENT; HISTOLOGY; HUMAN; LOWER ESOPHAGUS SPHINCTER; OBSERVER VARIATION; PRIORITY JOURNAL; REVIEW; SAMPLING; STOMACH FUNDUS;

BARRETT ESOPHAGUS; DISEASE PROGRESSION; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; ESOPHAGOSCOPY; HUMANS; PRECANCEROUS CONDITIONS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037393206     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000062996.66432.12     Document Type: Review

References (55)

1. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
2. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelial-lined (Barrett's) esophagus. Am J Clin Pathol 1978;70:1-5.
3. Haggitt RC. Adenocarcinoma in Barrett's esophagus. A new epidemic? Hum Pathol 1992;23:475-6.
4. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994;21:403-10.
5. Bombeck CT, Dillard DH, Nyhus LM. Muscular anatomy of the gastroesophageal junction and role of phrenoesophageal ligament. Autopsy study of sphincter mechanism. Ann Surg 1966;164:643-54.
6. Der R, Tsao-Wei DD, DeMeester T, Peters J, Groshen S, Lord RV. Carditis. A manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001;25:245-52.
7. Öberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226:522-32.
8. Chandrasoma PT, Lokuhetty DM, DeMeester TR, Bremner CG, Peters JH, Öberg S, et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 2000;24:344-51.
9. Owen DA. Stomach. In: Sternberg SS, editor. Histology for pathologists. New York: Raven Press; 1992. p. 533-45.
10. Chandrasoma PT, Der R, Ma Y, Dalton P, Taira M. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000;24:402-9.
11. Kilgore S, Ormsby AH, Gramlich TL, Rice TW, Richter JE, Falk GW, et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000;95:921-4.
12. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 1996;110:614-21.
13. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
14. Haggitt RC. Barrett's esophagus, dysplasia and adenocarcinoma. Hum Pathol 1994;25:982-93.
15. Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus. Goblets, goblets, goblets. Gastrointest Endosc 1996;44:91-4.
16. Sampliner RE. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 1998;93:1028-31.
17. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus - the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998;93:1033-6.
18. Weston AP, Krmpotich P, Makdisi WJ, Cherian R, Dixon A, McGregor DH, et al. Short-segment Barrett's esophagus: clinical and histological features, associated endoscopic findings and association with gastric intestinal metaplasia. Am J Gastroenterol 1996;91:981-6.
19. Offner FA, Lewin KJ, Weinstein WM. Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. Hum Pathol 1996;27:885-9.
20. Sjogren RW, Johnson LF. Barrett's esophagus: a review. Am J Med 1983;74:3131-40.
21. Hamilton SR, Smith RRL. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-12.
22. Lee RG. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients. Am J Surg Pathol 1985;9:845-52.
23. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Predictors of progression to malignancy in Barrett's esophagus: endoscopic, histologic and flow cytometric follow-up of a cohort. Gastroenterology 1992;102:1212-9.
24. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, VanDeventer G, Den Besten L, et al. Endoscopic biopsies diagnose high-grade dysplasia or early operable adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
25. Schmidt HG, Riddell RH, Walther B, Skinner DB, Riemann JF. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol 1985;110:145-52.
26. Smith RRL, Hamilton SR, Boitnott JK, Rogers EL. The spectrum of carcinoma arising in Barrett's esophagus: a clinicopathologic study of 26 patients. Am J Surg Pathol 1984;8:562-73.
27. Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
28. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-43.
29. Hirota WK, Loughney TN, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
30. Menke-Pluymers MBE, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. Cancer 1993;72:1155-8.
31. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999;49:170-6.
32. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical implications. Hum Pathol 1983;14:931-68.
33. Goseki M, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992;69:1088-93.
34. Sabik JF, Rice TW, Goldblum JR, Koka A, Kirby TJ, Medendorp SV, et al. Superficial esophageal carcinoma. Ann Thorac Surg 1995;60:896-902.
35. Ormsby AH, Petras RE, Henricks WH, Rice TW, Richter JE, Goldblum JR. Observer variation in the diagnosis of superficial adenocarcinoma. Gut 2002;51:671-6.
36. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
37. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, et al. Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation. Hum Pathol 2001;32:368-78.
38. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-6.
39. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000;95:3089-96.
40. Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000;95:1888-93.
41. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-19.
42. Petras RE, Sivak MV, Rice TW. Barrett's esophagus: a review of the pathologist's role in diagnosis and management. Pathol Annu 1991;26:1-32.
43. Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Flow cytometry complements histology in detecting patients at risk for Barrett's adenocarcinoma. Gastroenterology 1987;93:1-11.
44. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000;95:1669-76.
45. Fennerty MB, Sampliner RE, Way D, Riddell R, Steinbronn K, Garewal HS. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989;97:815-20.
46. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
47. Coppola D, Falcone R, Livingston S, Karl R, Nicosia S, Cacho CM. Cyclin D1 expression correlates with degrees of dysplasia in Barrett's esophagus. Lab Invest 1997;76:298-302.
48. Reid BJ, Sanchez CA, Blount PL, Levine DS. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993;105:119-29.
49. Morales CP, Lee EL, Shay JW. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 1998;83:652-9.
50. Mullick T, Tasch JE, Ormsby AH, Richter JE, Goldblum JR, Petras RE, et al. Telomerase upregulation in Barrett's esophagus precedes the development of esophageal adenocarcinoma. Am J Gastroenterol 2001;96:75A.
51. Casson AG, Mukhopadhay T, Cleary KR, Ro JY, Levin B, Roth JA. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991;51:4495-9.
52. Younes M, Lebovitz RM, Lechago LV, Lechago J. p53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma: a follow-up study. Gastroenterology 1993;105:1637-42.
53. Haamelin R, Flejou JF, Muzeau F, Potet F, Laurent-Puig P, Fekete F, et al. TP53 mutations, and p53 protein immunoreactivity in malignant and premalignant Barrett's oesophagus. Gastroenterology 1994;107:1012-8.
54. Younes M, Schwartz MR, Finnier D, Younes A. Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus. Hum Pathol 1999;30:1309-13.
55. Wu T-T, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998;153:287-94.